Publication: Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment
Issued Date
2001-11-24
Resource Type
ISSN
02507005
Other identifier(s)
2-s2.0-0035152386
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Anticancer Research. Vol.21, No.4 A (2001), 2739-2743
Suggested Citation
B. Chawengchao, S. Petmitr, M. Ponglikitmongkol, V. Chanyavanich, T. Sangruji, V. Theerapuncharoen, K. Hayashi, W. Thangnipon Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment. Anticancer Research. Vol.21, No.4 A (2001), 2739-2743. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/26437
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment
Other Contributor(s)
Abstract
Using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) with additional Klenow treatment and direct sequencing, mutations in the p53 tumor suppressor gene were analyzed from 21 cases of human astrocytomas. Three cases had p53 gene mutations: two of them were glioblastomas showing a point mutation, one in exon 5 and the other in 6. The last one was a gemistocytic astrocytoma showing a point mutation in exon 5. The frequency of p53 gene mutations in the astrocytomas examined was 14.3% (3 out of 21). No SSCP alterations were observed in any of the p53 fragments amplified from WHO grade I pilocytic astrocytomas and WHO grade III anaplastic astrocytomas. Further examination by direct sequencing showed that two mutations of glioblastomas had single-base substitutions resulting in silent and missense mutations, whereas one of the gemistocytic astrocytomas had a double-base substitution resulting in a missense mutation. The present studies revealed that all mutations were located outside the hot spots and, interestingly, one of them disclosed a missense mutation in exon 5 at codon 166, which was first detected in a grade H astrocytoma (gemistocytic type). It is possible that the missense mutation at this codon may be associated with special risk factors for the development of astrocytic tumors in Thai patients.